Literature DB >> 30359634

6-Hydroxydopamine induces different mitochondrial bioenergetics response in brain regions of rat.

Débora F Gonçalves1, Aline A Courtes1, Diane D Hartmann1, Pamela C da Rosa1, Débora M Oliveira1, Félix A A Soares1, Cristiane L Dalla Corte2.   

Abstract

Mitochondrial dysfunction has been demonstrated to have a central role in Parkinson Disease (PD) pathophysiology. Some studies have indicated that PD causes an impairment in mitochondrial bioenergetics; however, the effects of PD on brain-region specific bioenergetics was never investigated before. This study aimed to evaluate mitochondrial bioenergetics in different rat brain structures in an in vitro model of PD using 6-OHDA. Rat brain slices of hippocampus, striatum, and cortex were exposed to 6-OHDA (100 μM) for 1 h and mitochondrial bioenergetic parameters, peroxide production, lactate dehydrogenase (LDH) and citrate synthase (CS) activities were analyzed. Hippocampus slices exposed to 6-OHDA presented increased peroxide production but, no mitochondrial adaptive response against 6-OHDA damage. Cortex slices exposed to 6-OHDA presented increased oxygen flux related to oxidative phosphorylation and energetic pathways exchange demonstrated by the increase in LDH activity, suggesting a mitochondrial compensatory response. Striatum slices exposed to 6-OHDA presented a decrease of oxidative phosphorylation and decrease of oxygen flux related to ATP-synthase indicating an impairment in the respiratory chain. The co-incubation of 6-OHDA with n-acetylcysteine (NAC) abolished the effects of 6-OHDA on mitochondrial function in all brain regions tested, indicating that the increased reactive oxygen species (ROS) production is responsible for the alterations observed in mitochondrial bioenergetics. The present results indicate a brain-region specific response against 6-OHDA, providing new insights into brain mitochondrial bioenergetic function in PD. These findings may contribute to the development of future therapies with a target on energy metabolism.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  High-resolution respirometry; Mitochondrial function; Neurodegenerative disease; Parkinson disease; ROS production

Mesh:

Substances:

Year:  2018        PMID: 30359634     DOI: 10.1016/j.neuro.2018.10.005

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  2 in total

1.  6-Hydroxydopamine: a far from simple neurotoxin.

Authors:  Damir Varešlija; Keith F Tipton; Gavin P Davey; Andrew G McDonald
Journal:  J Neural Transm (Vienna)       Date:  2020-01-01       Impact factor: 3.575

2.  Caenorhabditis elegans as a model for studies on quinolinic acid-induced NMDAR-dependent glutamatergic disorders.

Authors:  Tássia Limana da Silveira; Marina Lopes Machado; Fabiane Bicca Obetine Baptista; Débora Farina Gonçalves; Diane Duarte Hartmann; Larissa Marafiga Cordeiro; Aline Franzen da Silva; Cristiane Lenz Dalla Corte; Michael Aschner; Felix Alexandre Antunes Soares
Journal:  Brain Res Bull       Date:  2021-07-13       Impact factor: 3.715

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.